Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma
about
Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studiesHepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinomaThe role of the hepatitis viruses in cholangiocarcinomaHBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis.Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reportsHepatitis B virus infection and intrahepatic cholangiocarcinoma.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisRisk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control studyIntra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literatureHepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Hepatocellular carcinoma in patients with chronic kidney diseaseAdvances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.Genetics of biliary tract cancers and emerging targeted therapies.Surgical outcomes of intrahepatic cholangiocarcinoma.Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review.Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.Organ system view of the hepatic innate immunity in HCV infection.Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma.The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case-control study.Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma.Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study.Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study.
P2860
Q26998595-029DBE5A-FA52-48FF-9B51-37E9181CA7B5Q28076535-CEB4242D-E517-4698-9B10-53E955F1238AQ28288613-D57F3720-4816-4597-B1B2-1D17047E013FQ30240015-B9A2590D-3C22-4DC6-82BE-9EFB06D6BF62Q31073665-AD0AF231-94D1-4ADC-93C7-F48193108EF2Q31145862-C5B2E07E-D0BE-4848-AC0D-E18E4E0F4762Q33626806-76AC943A-3713-4270-8A20-AE6898E4C692Q33829684-EA64C1D5-FD01-4935-9DA4-F8C29CE697F1Q33869560-CF0FBF96-A1D7-4FEC-9126-2C413417E8E0Q34045215-3893B0D8-94D1-4819-87A1-FB93BF8E5DDDQ34186338-94CA6363-8319-4289-BF78-A647C3624712Q34207893-ADE2D613-EDE6-4990-A3C8-38B0EF675345Q34398255-5C1184EF-2240-4EB7-84D0-12A8B236B670Q34486878-DEB77A79-1C6F-45E3-B207-F23B71F84EDBQ34744836-C493DDAB-3863-42E7-B8FE-23871F8679EAQ34874988-E56808EE-B603-4B03-9DAB-EAED7C480491Q34986048-EF34E142-057C-432E-93D5-2CE9DDAB8B23Q35868937-566F9DAE-96DE-45FB-AFB8-734CC558E192Q36052356-027E8991-7C0C-4F68-9B3B-A8184B8BB9ABQ36656633-398DA259-1EC3-4414-8156-9B7347BCE426Q36683019-34B21106-3ACD-475B-BA8D-D7EB89EE2145Q36821615-DB29FEA0-659E-481D-BBF4-9B98754D356EQ37347327-BFF121AA-D08F-42DE-8063-3C7A5CDDE5EDQ37709278-ACB1BFDF-EE4A-440D-BC86-572CC43DBF8CQ37718250-B539C6CC-52BD-4ED3-B72F-6944D1B1AA3AQ37765099-0757C224-5370-479A-BCFF-0E13337E6E5CQ37900232-B97F8090-2ACB-4277-A118-36C8B66E751FQ38018382-7EEAFC53-E280-487C-AB51-B9ECCFCCC7B6Q38254084-E9056CEE-EF28-45E1-AF38-EA4BAD132442Q38408925-34F5D489-105E-4BE2-8C6C-45AA0E78B068Q38410891-BAD70E90-B8AB-4319-82DE-E3E9B16F10AEQ38827613-532126E9-78DA-4207-BC59-08ABB141E094Q39310726-D6B98896-A3E6-4A59-A0DF-A2F254679D74Q40431873-F3D5976E-F4E7-41D9-9C4D-13C2ACB64D5CQ40842861-29B9718A-4BEC-4243-B753-1FB19E2512ACQ41290820-11A94C41-ADB2-409B-84B6-8042BEB229ACQ41626792-A074290A-193B-4A50-9305-A5C3FB43B385Q41721837-2853AFA7-C9E2-460D-9FD8-A7F084EADD96Q41991379-F62A8971-F28D-41E5-97E9-CF3CB467E670Q42376329-CD4A7269-3745-40BF-8841-CA271771073F
P2860
Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Viral hepatitis-associated int ...... with hepatocellular carcinoma
@en
Viral hepatitis-associated int ...... with hepatocellular carcinoma.
@nl
type
label
Viral hepatitis-associated int ...... with hepatocellular carcinoma
@en
Viral hepatitis-associated int ...... with hepatocellular carcinoma.
@nl
prefLabel
Viral hepatitis-associated int ...... with hepatocellular carcinoma
@en
Viral hepatitis-associated int ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Viral hepatitis-associated int ...... with hepatocellular carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605063
P407
P577
2009-05-12T00:00:00Z